intestazione

Back Publication Plan

The EUROCARE-5 Publication Plan is structured in three different phases: 

  • Phase-1 - Summary Results 
  • Phase-2 – EUROCARE-5 Monographic Issue 
  • Phase-3 – EUROCARE-5 further studies 

The authorship criteria for the EUROCARE-5 Publication Plan are described here: 

Authorship EUROCARE-5 Publication Plan 

The full list of publications of the EUROCARE-5 Study are available in Publications

 

Phase-1 - Summary Results on Cancer Survival in European patients, adults and children 

  • Adult cancer patients, Lancet Oncology 2014. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5-a population-based study. De Angelis R.; Sant M.; Coleman M.P.; Francisci S.; Baili P.; et al. Lancet Oncology 2014,15:23-34  
  • Childhood cancers, Lancet Oncology 2014. Childhood cancer survival in Europe 1999-2007: results of EUROCARE-5-a population-based study. Gatta G.; Botta L.; Rossi S.; Aareleid T.; Bielska-Lasota M.; et al. Lancet Oncology 2014,15:35:47 
  • Haematological Malignancies, Lancet Oncology 2014. Survival for haematological malignancies in Europe between 1997 and 2008 by region and age: results of EUROCARE-5, a population-based study. Sant M.; Minicozzi P.; Mounier M.; Anderson L.A.; Brenner H. et al. Lancet Oncology 2014,15:931-942

 

Phase-2 - EUROCARE-5 Monographic Issue, 2015

The EUROCARE-5 Special issue was presented by Milena Sant at the 18th ECCO - 40th ESMO European Cancer Congress in Vienna on September 26th 2015. The slides  are available here 

 

Phase-3 - EUROCARE-5 further studies 

The Phase -3 of the Publication Plan includes further studies based on the EUROCARE-5 dataset that were approved by the EUROCARE Steering Committee or by the Working Group during Plenary Assemblies. 

Published studies 

  • Follicular and diffuse large B-cell lymphomas, Lancet Haematology 2016. Changes in dynamics of excess mortality rates and net survival after diagnosis of follicular lymphoma or diffuse large B-cell lymphoma: comparison between European population-based data (EUROCARE-5). Mounier M.; Bossard N.; Remontet L.; Belot A.; Minicozzi P. et al. The Lancet Haematology 2015,11:e481-e491 
  • Adolescents and Young Adults, Lancet Oncology 2016. Survival of European adolescents and young adults diagnosed with cancer in 2000-07: population-based data from EUROCARE-5. Trama A; Botta L; Foschi R; Ferrari A; Stiller C; et al. The Lancet Oncology 2016,17:896-906 

Further approved study proposals 

 

Eurocare

EUROCARE-5

EUROCARE